cyclosporine and Dizzyness

cyclosporine has been researched along with Dizzyness in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Armengol, M; Azem, J; Buera, M; Cervera, C; Fort, JM; López-Cano, M; Ponseti, JM; Vilallonga, R	1
Chow, VF; Clucas, AT; Gladue, RP; Shah, A; Zhang, YD	1

Trials

2 trial(s) available for cyclosporine and Dizzyness

Article	Year
Long-term results of tacrolimus in cyclosporine- and prednisone-dependent myasthenia gravis. Neurology, 2005, May-10, Volume: 64, Issue:9 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Ataxia; Autoantibodies; Cyclosporine; Dizziness; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Muscle Weakness; Myasthenia Gravis; Prednisone; Prospective Studies; Receptors, Cholinergic; Remission Induction; Renal Insufficiency; Tacrolimus; Thymectomy; Time; Treatment Outcome	2005
Phase I evaluation of the safety, pharmacokinetics and pharmacodynamics of CP-481,715. Clinical pharmacokinetics, 2007, Volume: 46, Issue:9 Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Cross-Over Studies; Cyclosporine; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Fasting; Half-Life; Humans; Male; Metabolic Clearance Rate; Molecular Structure; Quinoxalines; Receptors, CCR1; Receptors, Chemokine	2007

Article

Year

Long-term results of tacrolimus in cyclosporine- and prednisone-dependent myasthenia gravis.

Neurology, 2005, May-10, Volume: 64, Issue:9

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Ataxia; Autoantibodies; Cyclosporine; Dizziness; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Muscle Weakness; Myasthenia Gravis; Prednisone; Prospective Studies; Receptors, Cholinergic; Remission Induction; Renal Insufficiency; Tacrolimus; Thymectomy; Time; Treatment Outcome

2005

Phase I evaluation of the safety, pharmacokinetics and pharmacodynamics of CP-481,715.

Clinical pharmacokinetics, 2007, Volume: 46, Issue:9

Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Cross-Over Studies; Cyclosporine; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Fasting; Half-Life; Humans; Male; Metabolic Clearance Rate; Molecular Structure; Quinoxalines; Receptors, CCR1; Receptors, Chemokine

2007